Associate Director, Regulatory Policy & Intelligence
Seagen Inc.
Chris Whalley brings 20 years experience in biotechnology & healthcare operations and is currently Associate Director of Regulatory Policy & Intelligence at Seagen Inc., a biopharmaceutical company focused on oncology therapies. Prior to joining Seattle Genetics, Chris established & led the global healthcare & life sciences regulatory program at Amazon Web Services, and he previously built regulatory & quality programs at Fred Hutchinson Cancer Research Center, Amgen, and a number of pre-commercial biotech companies in the Seattle area. Chris also founded and sold a publishing company catering to life science organizations, and he holds a patent on supplying regulatory compliance evidence for cloud service provider environments. When not at work, Chris enjoys spending time with his family and tending to his fruit and vegetable garden.
Disclosure information not submitted.
Saturday, September 10, 2022
8:30 AM – 4:00 PM MST
Monday, September 12, 2022
8:15 AM – 9:30 AM MST
Monday, September 12, 2022
4:35 PM – 5:30 PM MST